Highlights
description
It relieves mild to moderate pain associated with conditions such as colds, sore throat, headache, muscle or body aches, menstrual cramps, arthritis, and toothache. It is also effective in reducing fever. When taken within the recommended dosage, it is generally considered safe.
key benefits
Pain Relief and Treatment of Fever
side effects
Nausea, Vomiting, Allergic Reactions
alcohol interaction
Unsafe
pregnancy interaction
Safe If Prescribed
lactation interaction
Safe If Prescribed
driving interaction
Safe
kidney interaction
Caution
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited,Unit 601, Sakti Statesman, 6th floor, Green Glen Layout, No.37/301/34/1, SY.No.34, Ibblur Village, Begur Hobli Bangalore, Karnataka-560103 For Support ReachOut : support+geddit@zeptonow.com
Pharmacy License No.
KA-B12-284412, KA-B12-284413
Manufacturer or Marketer Name
Apex Laboratories Private Limited
Manufacturer or Marketer Address
Iii Floor Sidco Garment Complex, Guindy, Chennai 600 032, India
Country of Origin
India
Shelf Life
36 months
Expires on or after
November 2026
